Meiji Yasuda Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.73M Sell
61,430
-9,581
-13% -$559K 0.19% 146
2025
Q4
$3.83M Buy
71,011
+55,355
+354% +$2.66M 0.18% 155
2025
Q3
$706K Buy
15,656
+750
+5% +$35K 0.03% 291
2025
Q2
$690K Sell
14,906
-21,125
-59% -$1.04M 0.03% 290
2025
Q1
$2.2M Buy
36,031
+1,752
+5% +$102K 0.09% 224
2024
Q4
$1.94M Sell
34,279
-93
-0.3% -$5.2K 0.07% 228
2024
Q3
$1.78M Sell
34,372
-592
-2% -$27.8K 0.07% 246
2024
Q2
$1.45M Sell
34,964
-929
-3% -$41.6K 0.06% 263
2024
Q1
$1.95M Sell
35,893
-28,746
-44% -$1.46M 0.08% 220
2023
Q4
$3.32M Buy
64,639
+1,400
+2% +$73.5K 0.15% 177
2023
Q3
$3.67M Buy
63,239
+30,510
+93% +$1.87M 0.17% 164
2023
Q2
$2.09M Buy
32,729
+1,851
+6% +$124K 0.1% 205
2023
Q1
$2.14M Sell
30,878
-30,706
-50% -$2.17M 0.11% 204
2022
Q4
$4.43K Sell
61,584
-36,875
-37% -$2.78M 0.21% 137
2022
Q3
$7M Sell
98,459
-7,870
-7% -$571K 0.41% 68
2022
Q2
$8.19M Buy
106,329
+25,150
+31% +$1.92M 0.48% 46
2022
Q1
$5.93M Sell
81,179
-4,152
-5% -$279K 0.32% 80
2021
Q4
$5.32M Sell
85,331
-115
-0.1% -$6.75K 0.33% 76
2021
Q3
$5.06M Sell
85,446
-2,169
-2% -$143K 0.36% 72
2021
Q2
$5.85M Sell
87,615
-440
-0.5% -$28.7K 0.28% 79
2021
Q1
$5.56M Buy
88,055
+41,358
+89% +$2.57M 0.41% 67
2020
Q4
$2.9M Buy
46,697
+8,050
+21% +$495K 0.29% 100
2020
Q3
$2.33M Sell
38,647
-18,170
-32% -$1.09M 0.26% 104
2020
Q2
$3.34M Buy
56,817
+27,090
+91% +$1.62M 0.32% 79
2020
Q1
$1.66M Sell
29,727
-39,280
-57% -$2.4M 0.31% 79
2019
Q4
$4.43M Buy
69,007
+12,556
+22% +$719K 0.37% 70
2019
Q3
$2.86M Sell
56,451
-2,230
-4% -$105K 0.23% 116
2019
Q2
$2.66M Buy
58,681
+2,672
+5% +$124K 0.22% 118
2019
Q1
$2.67M Buy
56,009
+338
+0.6% +$16.8K 0.23% 116
2018
Q4
$2.89M Buy
55,671
+6,537
+13% +$351K 0.27% 101
2018
Q3
$3.05M Sell
49,134
-800
-2% -$47.5K 0.25% 106
2018
Q2
$2.76M Sell
49,934
-1,420
-3% -$76.7K 0.25% 107
2018
Q1
$3.25M Sell
51,354
-1,790
-3% -$115K 0.31% 87
2017
Q4
$3.26M Buy
53,144
+4,320
+9% +$270K 0.31% 86
2017
Q3
$3.11M Sell
48,824
-10
-0% -$584 0.31% 94
2017
Q2
$2.72M Buy
48,834
+680
+1% +$37K 0.28% 102
2017
Q1
$2.62M Buy
48,154
+1,670
+4% +$91.6K 0.28% 100
2016
Q4
$2.72M Sell
46,484
-20,230
-30% -$1.11M 0.3% 90
2016
Q3
$3.6M Buy
66,714
+13,040
+24% +$838K 0.42% 68
2016
Q2
$3.95M Buy
53,674
+27,880
+108% +$1.97M 0.57% 49
2016
Q1
$1.65M Sell
25,794
-120
-0.5% -$7.57K 0.37% 74
2015
Q4
$1.78M Sell
25,914
-900
-3% -$59.5K 0.4% 68
2015
Q3
$1.59M Buy
26,814
+1,810
+7% +$115K 0.39% 71
2015
Q2
$1.66M Buy
25,004
+2,470
+11% +$163K 0.39% 70
2015
Q1
$1.45M Buy
22,534
+330
+1% +$20.7K 0.35% 76
2014
Q4
$1.31M Sell
22,204
-2,690
-11% -$152K 0.32% 83
2014
Q3
$1.27M Sell
24,894
-470
-2% -$23.5K 0.3% 84
2014
Q2
$1.23M Sell
25,364
-6,998
-22% -$345K 0.25% 89
2014
Q1
$1.68M Buy
32,362
+2,780
+9% +$148K 0.36% 72
2013
Q4
$1.57M Sell
29,582
-900
-3% -$45.8K 0.33% 77
2013
Q3
$1.41M Buy
30,482
+470
+2% +$20.6K 0.32% 84
2013
Q2
$1.37M Buy
+30,012
New +$1.3M 0.32% 85

Other funds holding BMY

Meiji Yasuda Asset Management's BMY Position: Q1 2026 in Review

Meiji Yasuda Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, selling an estimated $559K and leaving 61,430 shares worth $3.73M. The position accounts for 0.19% of the portfolio, ranked #146.

Meiji Yasuda Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.19M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Meiji Yasuda Asset Management held 61,430 shares of Bristol-Myers Squibb worth $3.73M as of Q1 2026.
  • Meiji Yasuda Asset Management sold 9,581 Bristol-Myers Squibb shares in Q1 2026, an estimated $559K.
  • Bristol-Myers Squibb made up 0.19% of Meiji Yasuda Asset Management's portfolio in Q1 2026, its #146 holding.
  • Meiji Yasuda Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Meiji Yasuda Asset Management's Bristol-Myers Squibb position peaked at $8.19M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q1 2026, filed 14 May 2026.